Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

6.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OT-55 reshapes tolerogenic BH3-mimetic-induced apoptosis toward immunogenic cell death in acute myeloid leukemia, potentiating PD-1/Tim-3 blockade.

Cell death & disease·2026
Same author

Selective HDAC6 inhibition perturbs autophagy and enhances integrated stress response-mediated immunogenic apoptosis in chronic myeloid leukemia.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemia.

Cancer letters·2025
Same author

Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Clinical epigenetics·2025
Same author

Marine Natural Products as Anticancer Agents 3.0.

Marine drugs·2025
Same author

Bone marrow tumor microenvironment profiling predicts distinct immunosuppressive phenotypes and immunotherapy potential in AML patients.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025

Related Experiment Video

Updated: Apr 27, 2026

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
09:44

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Published on: September 5, 2019

6.6K

Plumbagin modulates leukemia cell redox status.

François Gaascht1, Marie-Hélène Teiten2, Claudia Cerella3

  • 1Laboratoire de Biologie Moléculaire et Cellulaire du Cancer (LBMCC), Hôpital Kirchberg, 9, Rue Edward Steichen, L-2540 Luxembourg, Grand-Duchy of Luxembourg. francois.gaascht@lbmcc.lu.

Molecules (Basel, Switzerland)
|July 12, 2014
PubMed
Summary

Plumbagin, a plant compound, shows anti-cancer effects by inducing apoptosis and reactive oxygen species (ROS). Its effectiveness in leukemia cells depends on cellular thiol levels, which influence ROS production and cell death.

More Related Videos

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

8.6K
Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

9.7K

Related Experiment Videos

Last Updated: Apr 27, 2026

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
09:44

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Published on: September 5, 2019

6.6K
Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

8.6K
Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

9.7K

Area of Science:

  • Pharmacology
  • Biochemistry
  • Cancer Biology

Background:

  • Plumbagin, a natural naphtoquinone, exhibits anti-cancer properties.
  • It induces apoptotic cell death and generates reactive oxygen species (ROS).
  • Differential sensitivity of leukemia cells to plumbagin requires further investigation.

Purpose of the Study:

  • To identify factors contributing to varying leukemia cell sensitivity to plumbagin.
  • To investigate the role of reactive oxygen species (ROS) in plumbagin-induced cytotoxicity.
  • To explore the influence of cellular thiol status on plumbagin's anti-cancer effects.

Main Methods:

  • Comparative analysis of plumbagin's effects on U937 (monocytic leukemia) and Raji (Burkitt lymphoma) cell lines.
  • Assessment of cytotoxicity, apoptotic cell death, and ROS production.
  • Evaluation of plumbagin incorporation and efflux.
  • Investigation using thiol-containing and non-thiol-containing antioxidants.

Main Results:

  • U937 cells were more sensitive to plumbagin than Raji cells, showing higher cytotoxicity and apoptosis.
  • U937 cells produced ten times more ROS than Raji cells after plumbagin treatment.
  • No significant differences in plumbagin incorporation or efflux were observed between cell lines.
  • Thiol-containing antioxidants, but not non-thiol-containing ones, inhibited ROS production and apoptosis.

Conclusions:

  • Leukemia cell sensitivity to plumbagin is linked to its pro-oxidant activity.
  • Cellular thiolstat plays a critical role in mediating plumbagin's anti-cancer effects via ROS generation.
  • Targeting cellular thiols could enhance plumbagin's therapeutic potential in leukemia treatment.